Systematic Review of Clinical and Economic Evidence for Primary Open- Angle Glaucoma Therapy with Tafluprost vs Travoprost

1
Surayyo Z. Yuldasheva
Surayyo Z. Yuldasheva
2
Shoyusuf F. Shodmanov
Shoyusuf F. Shodmanov
3
Shakhnoza Z. Umarova
Shakhnoza Z. Umarova
4
Zoya R. Usmanova
Zoya R. Usmanova

Send Message

To: Author

GJMR Volume 22 Issue F3

Article Fingerprint

ReserarchID

R1271

Systematic Review of Clinical and Economic Evidence for Primary Open-  Angle Glaucoma Therapy with Tafluprost vs Travoprost Banner
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Background: According to WHO, the number of patients with glaucoma in the world ranges from 60.5 to 105 million people, and the number of such patients is also predicted to increase to 80 million. Out of 28 million blind people in the world almost one in five lost their sight due to glaucoma. The aim of this research is to conduct a systematic review of the clinical and economic evidence for the treatment of primary open-angle glaucoma with Tafluprost vs Travoprost.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

Surayyo Z. Yuldasheva. 2026. \u201cSystematic Review of Clinical and Economic Evidence for Primary Open- Angle Glaucoma Therapy with Tafluprost vs Travoprost\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 22 (GJMR Volume 22 Issue F3): .

Download Citation

High-quality alt text emphasizing clinical, economic, and research evidence in open-angle glaucoma treatment.
Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: DDC Code: 617.741 LCC Code: RE871
Version of record

v1.2

Issue date

April 1, 2022

Language

English

Experiance in AR

The methods for personal identification and authentication are no exception.

Read in 3D

The methods for personal identification and authentication are no exception.

Article Matrices
Total Views: 1572
Total Downloads: 27
2026 Trends
Research Identity (RIN)
Related Research

Published Article

Background: According to WHO, the number of patients with glaucoma in the world ranges from 60.5 to 105 million people, and the number of such patients is also predicted to increase to 80 million. Out of 28 million blind people in the world almost one in five lost their sight due to glaucoma. The aim of this research is to conduct a systematic review of the clinical and economic evidence for the treatment of primary open-angle glaucoma with Tafluprost vs Travoprost.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]
×

This Page is Under Development

We are currently updating this article page for a better experience.

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Systematic Review of Clinical and Economic Evidence for Primary Open- Angle Glaucoma Therapy with Tafluprost vs Travoprost

Shoyusuf F. Shodmanov
Shoyusuf F. Shodmanov
Shakhnoza Z. Umarova
Shakhnoza Z. Umarova
Zoya R. Usmanova
Zoya R. Usmanova

Research Journals